Latka logo
Oxford Drug Design logo

Oxford Drug Designrevenue & funding

Data Science and Machine Learning PlatformsOxford, United KingdomFounded 2001CEO Graham Richards

Oxford Drug Design is a Data Science and Machine Learning Platforms company based in Oxford, founded in 2001.

oxforddrugdesign.comLinkedInUpdated Oct 17, 2024
Annual revenue
$2.7M
Oct 2024EST.
Total raised
$12.4M
5 rounds
Employees
11
Oct 2024

Oxford Drug Design revenue

Oxford Drug Design has not published its revenue. GetLatka estimates it at about $2.7M a year (October 2024).

$0
$1M
$2M
$709.9K
$1.1M
$1.4M
$2.7M
2021202220232024
ReportedEstimateOne figure per year; a reported figure wins over an estimate
All 4 revenue readings, with sources
As ofRevenueSource
Apr 2021$709.9K–
May 2022$1.1M–
Nov 2023$1.4MEST.GetLatka estimate
Oct 2024$2.7MEST.GetLatka estimate

– source not recorded

Oxford Drug Design funding rounds & investors

Oxford Drug Design has raised $12.4M across five rounds since 2006. The latest was a $2.7M Convertible Note in May 2022.

DateRoundRaised
May 2022Convertible Note$2.7M
Nov 2019Venture$2.7M
May 2019Grant$3.2M
Apr 2017Series A$1.2M
Nov 2006Venture$2.4M
Total raised$12.4M

Oxford Drug Design CEO, founders & employees

Graham Richards founded Oxford Drug Design in 2001 and runs it as CEO. Oxford Drug Design had 11 employees (October 2024, LinkedIn).

0
5
10
7
7
9
11
11
20202021202220232024
ReportedOne figure per year; a reported figure wins over an estimate
All 7 headcount readings, with sources
As ofEmployeesSource
Oct 202411LinkedIn
Nov 202311–
Nov 20229–
May 20229–
Nov 20217–
Apr 202125–
Nov 20207–

Oxford Drug Design FAQ

What is Oxford Drug Design's revenue?

GetLatka estimates Oxford Drug Design's revenue at about $2.7M a year (October 2024). The company hasn't published its own figure.

How much funding has Oxford Drug Design raised?

Oxford Drug Design has raised $12.4M across five funding rounds. The latest was a $2.7M Convertible Note in May 2022.

How many employees does Oxford Drug Design have?

Oxford Drug Design had 11 employees in October 2024, according to LinkedIn.

Who is the CEO of Oxford Drug Design?

Graham Richards is the CEO of Oxford Drug Design and founded the company in 2001.

Who founded Oxford Drug Design?

Graham Richards founded Oxford Drug Design in 2001.

How this page is sourced

1 from public sources · 2 estimates. Founder figures link to the second they were said; public figures name their source; estimates are marked EST. and say whose they are. Not financial advice.

Updated Oct 17, 2024Data disclaimerReport a correctionClaim this profileRun Oxford Drug Design? Join the podcast